Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.

The World Health Organization recently lowered the rifampin (RIF) critical concentration (CC) for drug-susceptibility testing (DST) of Mycobacterium tuberculosis complex (MTBC) using the mycobacterial growth indicator tube (MGIT) 960 system. Here, we evaluated the diagnostic performance of the MGIT system with the revised CC for determining MTBC RIF resistance with 303 clinical MTBC isolates, including 122 isolates with rpoB mutations, of which 32 had single borderline-resistance mutations, and 181 wild-type rpoB isolates. The phenotypic RIF resistance was determined via the absolute concentration method (AC) and via MGIT using both previous (1 mg/L) and revised (0.5 mg/L) CCs for the latter method. The diagnostic accuracy of each phenotypic DST (pDST) was assessed based on rpoB genotyping as the reference standard. The overall sensitivity of the AC was 95.1% (95% confidence interval [CI], 89.6 to 98.2%), while the MGIT results with previous and revised CCs were 82.0% (95% CI 74.0 to 88.3%) and 83.6% (95% CI 75.8 to 89.7%), respectively. The 32 MTBC isolates with single borderline-resistance mutations showed a wide range of MICs, and sensitivity was not significantly increased by reducing the MGIT CC. All 181 wild-type rpoB isolates were RIF-susceptible in the AC and with MGIT using the previous CC, whereas 1 isolate was misclassified as RIF-resistant with the revised CC. Our results demonstrate that the overall diagnostic performances of the MGIT DST with the revised RIF CC and previous CC were comparable. A further large-scale study is required to demonstrate the optimal RIF CC for MGIT.

The first case of cholecytitis caused by Aggregatibacter kilianii in Korea.

BACKGROUND: The bacterial genus Aggregatibacter was categorized in 2006 to accommodate the former Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, and H. segnis species. Aggregatibacter kilianii is a normal resident of the human upper respiratory tract but can also cause serious infections. A. kilianii is relatively newly identified and has been isolated from conjunctivitis, wounds, abdominal abscesses, and blood. CASE PRESENTATION: An 80-year-old female patient with distal common bile duct cancer was admitted to our hospital with sudden loss of consciousness and general weakness, fever, and abdominal pain for 3 days. Two colonial morphologies were isolated from both the blood and bile cultures; one was identified as Streptococcus constellatus subsp. pharyngis, but the other was not recognized by Vitek2 and MALDI-TOF. The 16 S rRNA sequences showed 99.73% similarity with the sequence of A. kilianii strains. CONCLUSION AND DISCUSSION: This article presents the first case of a clinical isolate of A. kilianii outside Europe. This case is also the first of the antimicrobial profile of this strain. This report highlights the importance of proper molecular identification for timely diagnosis and treatment of disease.

Fatal Prototheca zopfii Algaemia in a Patient with Acute Lymphoblastic Leukemia: a Case Report.

BACKGROUND: Prototheca algaemia is a rare but life-threatening disease that occurs primarily in immunocompromised patients. We report a fatal case of Prototheca zopfii bloodstream infection in a 54-year-old woman receiving chemotherapy for relapsed acute lymphoblastic leukemia. METHODS: The isolate was identified using an automated biochemical identification system (VITEK 2; bioMerieux) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (VITEK MS; bioMerieux). Partial 18S and 28S rDNA sequencing was performed for definitive identification and genotyping. RESULTS: The patient had persistent neutropenic fever, and isolates from blood culture were identified as P. zopfii. Sequencing was performed and the isolate was confirmed to be P. zopfii genotype 2, which was newly named as P. bovis. The patient was treated with liposomal amphotericin B but died of septic shock. CONCLUSIONS: Prototheca spp. should be considered an emerging pathogen, especially in immunocompromised patients, due to its ubiquitous nature.

Antibacterial and anticandidal effects of atmospheric-pressure, non-thermal, nitrogen- and argon-plasma pulses.

Atmospheric-pressure, non-thermal plasma destroys microorganisms by directly reacting with hydrocarbon molecules in the cell wall and/or by damaging the cytoplasmic membrane, proteins, and DNA with charged particles and reactive species. The aim of our study was to evaluate the antibacterial and anticandidal effects of atmospheric-pressure, non-thermal, nitrogen- and argon-plasma pulses on various pathogen preparations. The resultant antibacterial and anticandidal effects were assessed by evaluating percent and log reduction values for pathogen colonies. Nitrogen-plasma pulses emitted at an energy of 1.5 J and argon-plasma pulses generated at 0.5 J elicited remarkable antibacterial effects on Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus (MRSA) and anticandidal effects on Candida albicans. Nitrogen-plasma pulses at a pulse count of five elicited remarkable antibacterial effects on Cutibacterium acnes at the energy settings of 1.75, 2.5, and 3 J, but not at 1 J. Meanwhile, argon-plasma pulses showed antibacterial effects on C. acnes at an energy of 0.5 and 0.65 J. Nitrogen- or argon-plasma pulses exert antibacterial and anticandidal effects on bacterial and fungal pathogens.

A Feasibility Study of Photovoltaic-Electrolysis-PEM Hybrid System Integrated Into the Electric Grid System Over the Korean Peninsula.

A photovoltaic-electrolysis-PEM hybrid model was developed for a feasibility study, and simulations of several scenarios in Korea were performed. The solar irradiance was derived from the University of Arizona solar irradiance based on satellite-Korea Institute of Energy Research model which provides the satellite imagery over the Korean peninsula every 15 min. In Korea, the annual average solar irradiance is 1,310 kWh m-2 with a maximum of 1,440 kWh m-2 in 2017. Electricity load and solar irradiance information were used to test the performance model of the photovoltaic-electrolysis-PEM hybrid system for baseload and several peak load shave runs. When the baseload was set at 4200 MW, the total capacity of the Photovoltaic plants was 58.5 GWp. In contrast, the hybrid system reduced the peak load more efficiently during daytime. In particular, the capacity factor of the Proton Exchange Membrane system increased in winter because the solar irradiance is relatively weak in that season. These results provide useful insights for the development of control logic models for the PV-electrolysis-PEM system in micro-grid setups.

Well-dispersed Te-doped mesoporous carbons as Pt-free counter electrodes for high-performance dye-sensitized solar cells.

A tellurium-doped carbon nanomaterial (Te-MC(P)) was newly developed by the soft-templated carbonization of the PAN-b-PBA copolymer with poly(3-hexyltellurophene). Te-MC(P) was characterized with various characterization methods, including the nitrogen sorption isotherm measurement (BET), X-ray photoelectron spectroscopy (XPS) and energy-dispersive X-ray spectroscopy (EDS), which reveal that the Te atoms are homogeneously dispersed in the three-dimensional hierarchical, graphite-like mesoporous carbon matrix with a Te doping level of 0.27 atom %. Based on the characterization results, the electrocatalytic ability of Te-MC(P) was evaluated by using a symmetrical dummy cell test with both Co(bpy)32+/3+ (bpy = 2,2'-bipyridine) and I-/I3- redox electrolytes as counter electrodes (CEs). The Te-MC(P) CEs showed remarkably lower charge-transfer resistance (Rct) values by approximately 10 times in the electrochemical impedance spectroscopy (EIS) measurement, compared to the counterpart platinum (Pt) and the tellurium-based material (Te-MC(A)), prepared with a telluric acid precursor that has a lower Te doping level of 0.15 at%. As a result, the excellent electrocatalytic ability of Te-MC(P) resulted in the improvement of photovoltaic performance. The power conversion efficiencies (PCEs) of Te-MC(P)-based dye-sensitized solar cells (DSSCs) were 12.69% for the Co(bpy)32+/3+ redox electrolyte with the SGT-021 porphyrin dye and 9.73% for the I-/I3- redox electrolyte with the N719 ruthenium dye. Furthermore, Te- MC(P) CEs exhibited remarkable electrochemical stability in the two redox electrolytes. These results could suggest that the Te-MC(P) CE is one of the best promising alternatives to Pt CEs as a low-cost, highly stable and efficient electrocatalytic CE for practical applications.

Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins.

The spike (S) protein mutations of SARS-CoV-2 are of major concern in terms of viral transmission and pathogenesis. Hence, we developed a PCR-based method to rapidly detect the 6 mutational hotspots (H49Y, G476S, V483A, H519Q, A520S, and D614G) in the S protein and applied this method to analyze the hotspots in the viral isolates from different geographical origins. Here, we identified that there was only the D614G mutation in the viral isolates. As of September 30, 2020, the analysis of 113,381 sequences available from the public repositories revealed that the SARS-CoV-2 variant carrying G614 has become the most prevalent form globally. Our results support recent epidemiological and genomic data demonstrating that the viral infectivity and transmission are enhanced by the S protein D614G mutation.

Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.

Commercially available reverse transcription-polymerase chain reaction (RT-PCR) kits are being used as an important tool to diagnose SARS-CoV-2 infection in clinical laboratories worldwide. However, some kits lack sufficient clinical evaluation due to the need for emergency use caused by the current COVID-19 pandemic. Here we found that a novel insertion/deletion mutation in the nucleocapsid (N) gene of SARS-CoV-2 samples is a cause of negative results for the N gene in a widely used assay that received emergency use authorization (EUA) from US FDA and Conformite Europeenne-in vitro diagnostics (CE-IVD) from EU. Although SARS-CoV-2 is diagnosed positive by other target probes in the assay, our findings provide an evidence of the genetic variability and rapid evolution of SARS-CoV-2 as well as a reference in designing commercial RT-PCR assays.

Nationwide seroprevalence of hepatitis A in South Korea from 2009 to 2019.

Hepatitis A, an acute type of hepatitis caused by the hepatitis A virus, occurs worldwide. Following the 2009 hepatitis A epidemic in South Korea, patient outbreak reports were collectively converted to an "all-patient report" in 2011, and national immunization programs were introduced for children in 2015. In this study, we aimed to analyze the changes and characteristics of hepatitis A antibody titers in South Korea following the epidemic. The results of hepatitis A antibody tests performed at clinical laboratories from 2009 to 2019 were analyzed based on year, age, region, sex, and medical institution. The average 2009-2018 positive anti-hepatitis A virus immunoglobulin G rate was 51.8%, but it increased (56.06%) in 2019. Significantly different antibody-positive rates were observed based on age: <10 years, 54.5%; 20-29 years, 19.5%; ≥50 years, almost 100%. The positive rate of individuals in their teens and 20s gradually increased, whereas that of those in their 30s and 40s gradually decreased. Males had higher antibody-positive rates than females, and samples from higher-level general hospitals exhibited higher antibody rates. The positive anti-hepatitis A virus immunoglobulin M rates gradually decreased after 2009 and were <1% after 2012. However, a high positive rate of 3.69% was observed in 2019 when there was an epidemic. Anti-hepatitis A virus immunoglobulin G-positive rates were similar throughout the year, but the anti-hepatitis A virus immunoglobulin M-positive rates increased from January, peaked in April, and decreased from July, exhibiting distinct seasonality. This is considered to be related to groundwater pollution during the spring drought season. The introduction of the "all-patient report" and national vaccination program for children has had an effective influence on hepatitis A management. However, for hepatitis A prevention, policy considerations for high-risk age groups with low antibody-positive rates will be necessary.

Three-dimensional tellurium and nitrogen Co-doped mesoporous carbons for high performance supercapacitors.

Tellurium-doped mesoporous carbon composite materials (Te/NMC) have been prepared by a facile intercalation method in the presence of nitrogen-doped mesoporous carbon (NMC) with tellurium powder, for the first time. The effects of the co-doped N and Te in the mesoporous carbon matrix on the physical/chemical properties and capacitance performances were investigated via the use of various characterization methods and electrochemical studies. The as-prepared NMC and Te/NMC materials were found to mainly be composed of mesopores and maintained the 3D hierarchical graphite-like structure with lots of defect sites. By intercalation of Te atoms into the NMC materials, 2.12 at% (atom%) of Te was doped into NMC and the specific surface area of Te/NMC (261.07 m2 g-1) decreased by about 1.5 times compared to that of NMC (437.96 m2 g-1). In electrochemical measurements as a supercapacitor (SC) electrode, the Te/NMC based electrode, even with its lower porosity parameters, exhibited a higher capacitive performance compared to the NMC-based electrode. These results for Te/NMC arise due to the pseudo-capacitive effect of doped Te and the increase in the capacitive area available from the formation of interconnections in the mesoporous carbons through Te-O bonds. As a result, the synergetic effect of the Te and N atoms enables Te/NMC to exhibit the highest specific capacitance of 197 F g-1 at a current density of 0.5 A g-1. Moreover, remarkable long-term cycling stability with the retention of more than 95% of the initial capacitance is observed for Te/NMC at a current density of 5 A g-1 and also for 1000 charge-discharge cycles.

In situ preparation of Ru-N-doped template-free mesoporous carbons as a transparent counter electrode for bifacial dye-sensitized solar cells.

The development of a highly active, long-lasting, and cost-effective electrocatalyst as an alternative to platinum (Pt) is a vital issue for the commercialization of dye-sensitized solar cells. In this study, Ru-N-doped template-free mesoporous carbon (Ru-N-TMC) was prepared by the direct stabilization and carbonization of the poly(butyl acrylate)-b-polyacrylonitrile (PBA-b-PAN) block copolymer and ruthenium(iii) acetylacetonate [Ru(acac)3]. During the stabilization process, microphase separation occurred in the PBA-b-PAN block copolymer due to the incompatibility between the two blocks, and the PAN block transformed to N-doped semi-graphitic carbon. In the carbonization step, the PBA block was eliminated as a porous template, creating hierarchal mesopores/micropores. Meanwhile, Ru(acac)3 was decomposed to Ru, which was homogeneously distributed over the carbon substrate and anchored through N and O heteroatoms. The resulting Ru-N-TMC showed ultra-low charge transfer resistance (Rct = 0.034 Ω cm2) in the Co(bipyridine)33+/2+ reduction reaction, indicating very high electrocatalytic ability. Even though it is a transparent counter electrode (CE, average visible transmittance of 42.25%), covering a small fraction of the fluorine doped tin oxide (FTO)/glass substrate with Ru-N-TMC, it led to lower charge transfer resistance (Rct = 0.55 Ω cm2) compared to Pt (Rct = 1.00 Ω cm2). The Ru-N-TMC counter electrode exhibited a superior power conversion efficiency (PCE) of 11.42% compared to Pt (11.16%) when employed in SGT-021/Co(bpy)33+/2+ based dye-sensitized solar cells (DSSCs). Furthermore, a remarkable PCE of 10.13% and 8.64% from front and rear illumination, respectively, was obtained when the Ru-N-TMC counter electrode was employed in a bifacial DSSC. The outstanding catalytic activity and PCE of Ru-N-TMC were due to the high surface area of Ru-N-TMC, which contained numerous active species (Ru and N), easily facilitated to redox ions through the hierarchical microporous/mesoporous structure.

Tellurium-Doped, Mesoporous Carbon Nanomaterials as Transparent Metal-Free Counter Electrodes for High-Performance Bifacial Dye-Sensitized Solar Cells.

Tellurium-doped, mesoporous carbon nanomaterials with a relatively high doping level were prepared by a simple stabilization and carbonization method in the presence of a tellurium metalloid. A transparent counter electrode (CE) was prepared using tellurium-doped, mesoporous carbon (TeMC) materials, and was directly applied to bifacial, dye-sensitized solar cells (DSSCs). To improve the performance of the bifacial DSSC device, CEs should have outstanding electrocatalytic activity, electrical conductivity, and electrochemical stability, as well as high transparency. In this study, to make transparent electrodes with outstanding electrocatalytic activity and electrical conductivity, various TeMC materials with different carbonization temperatures were prepared by simple pyrolysis of the polyacrylonitrile-block-poly (n-butyl acrylate) (PAN-b-PBA) block copolymer in the presence of the tellurium metalloid. The electrocatalytic activity of the prepared TeMC materials were evaluated through a dummy cell test, and the material with the best catalytic ability was selected and optimized for application in bifacial DSSC devices by controlling the film thickness of the CE. As a result, the bifacial DSSC devices with the TeMC CE exhibited high power conversion efficiencies (PCE), i.e., 9.43% and 8.06% under front and rear side irradiation, respectively, which are the highest values reported for bifacial DSSCs to date. Based on these results, newly-developed transparent, carbon-based electrodes may lead to more stable and effective bifacial DSSC development without sacrificing the photovoltaic performance of the DSSC device.

Application of the Whole Genome-Based Bacterial Identification System, TrueBac ID, Using Clinical Isolates That Were Not Identified With Three Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Systems.

BACKGROUND: Next-generation sequencing is increasingly used for taxonomic identification of pathogenic bacterial isolates. We evaluated the performance of a newly introduced whole genome-based bacterial identification system, TrueBac ID (ChunLab Inc., Seoul, Korea), using clinical isolates that were not identified by three matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems and 16S rRNA gene sequencing. METHODS: Thirty-six bacterial isolates were selected from a university-affiliated hospital and a commercial clinical laboratory. Species was identified by three MALDI-TOF MS systems: Bruker Biotyper MS (Bruker Daltonics, Billerica, MA, USA), VITEK MS (bioMérieux, Marcy l'Étoile, France), and ASTA MicroIDSys (ASTA Inc., Suwon, Korea). Whole genome sequencing was conducted using the Illumina MiSeq system (Illumina, San Diego, CA, USA), and genome-based identification was performed using the TrueBac ID cloud system (www.truebacid.com). RESULTS: TrueBac ID assigned 94% (34/36) of the isolates to known (N=25) or novel (N=4) species, genomospecies (N=3), or species group (N=2). The remaining two were identified at the genus level. CONCLUSIONS: TrueBac ID successfully identified the majority of isolates that MALDI-TOF MS failed to identify. Genome-based identification can be a useful tool in clinical laboratories, with its superior accuracy and database-driven operations.

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

BACKGROUND: Treatment success rates of multidrug-resistant tuberculosis (MDR-TB) remain unsatisfactory, and long-term use of second-line anti-TB drugs is accompanied by the frequent occurrence of adverse events, low treatment compliance, and high costs. The development of new efficient regimens with shorter treatment durations for MDR-TB will solve these issues and improve treatment outcomes. METHODS: This study is a phase II/III, multicenter, randomized, open-label clinical trial of non-inferiority design comparing a new regimen to the World Health Organization-endorsed conventional regimen for fluoroquinolone-sensitive MDR-TB. The control arm uses a conventional treatment regimen with second-line drugs including injectables for 20-24 months. The investigational arm uses a new shorter regimen including delamanid, linezolid, levofloxacin, and pyrazinamide for 9 or 12 months depending on time to sputum culture conversion. The primary outcome is the treatment success rate at 24 months after treatment initiation. Secondary outcomes include time to sputum culture conversion on liquid and solid media, proportions of sputum culture conversion on liquid media after 2 and 6 months of treatment, treatment success rate according to pyrazinamide resistance, and occurrence of adverse events grade 3 and above as evaluated by the Common Terminology Criteria for Adverse Events. Based on an α = 0.025 level of significance (one-sided test), a power of 80%, and a < 10% difference in treatment success rate between the control and investigational arms (80% vs. 70%) when the anticipated actual success rate in the treatment group is assumed to be 90%, the number of participants needed per arm to show non-inferiority of the investigational regimen was calculated as 48. Additionally, assuming the proportion of fluoroquinolone-susceptible MDR-TB among participants as 50%, and 5% loss to follow-up, the number of participants is calculated as N/( 0.50 × 0.95), resulting in 102 persons per group (204 in total). DISCUSSION: This trial will reveal the effectiveness and safety of a new shorter regimen comprising four oral drugs, including delamanid, linezolid, levofloxacin, and pyrazinamide, for the treatment of fluoroquinolone-sensitive MDR-TB. Results from this trial will provide evidence for adopting a shorter and more convenient treatment regimen for MDR-TB. TRIAL REGISTRATION: ClincalTrials.gov, NCT02619994 . Registered on 2 December 2015.

Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.

In this study, we aimed to retrospectively investigate and compare the drug susceptibility patterns of two major Mycobacterium abscessus complex (MABC) species; M. abscessus and M. massiliense. A total of 546 MABC respiratory isolates (277 M. abscessus and 269 M. massiliense) from 2011 to 2016 were analyzed in this study. We estimated minimum inhibitory concentrations (MICs) using the broth microdilution method, and we calculated MIC50 and MIC90 values from the MIC distribution. Both M. abscessus and M. massiliense were highly susceptible to amikacin and linezolid. For M. abscessus, the proportions of inducible and acquired resistance to clarithromycin were 68.6% and 12.3%, respectively. Only 15.2% of M. abscessus remained susceptible at day 14. On the other hand, none of the M. massiliense showed inducible resistance and 6.3% showed acquired resistance to clarithromycin. A total of 92.6% of the M. massiliense remained susceptible at day 14. The resistance rate of M. abscessus to moxifloxacin (90.3%) was significantly higher than that of M. massiliense (83.3%; p = 0.016). These susceptibility differences may explain the divergent treatment outcomes between patients with pulmonary disease caused by these two species.

Evaluation of the performance of two real-time PCR assays for detecting Mycobacterium species.

BACKGROUNDS: Rapid discrimination between Mycobacterium tuberculosis (MTB) and nontuberculous mycobacteria (NTM) is critical for patient treatment and to avoid unnecessary expenditure on infection control. Because real-time PCR assays distinguish MTB from NTM, we evaluated the performance of two real-time PCR assays (AdvanSure and PowerChek). METHODS: This study used 143 DNA samples from respiratory specimens which were collected based on routine PCR results using Anyplex kit. A total of 87 positive samples (65 MTB and 22 NTM) and 56 negative samples were collected consecutively during 6 months and 1 month, respectively. The diagnostic performance of PCR assays (AdvanSure and PowerChek) was retrospectively analyzed based on the results of conventional mycobacterial tests and routine PCR assay. RESULTS: Based on culture results, the sensitivities/specificities of AdvanSure and PowerChek were 90.7%/87.6% and 92.6%/85.4%, respectively, for MTB detection. For PCR-positive specimens, the quantification cycle (Cq) values of smear-negative specimens were higher than those of the smear-positive specimens (P < 0.001). As expected, the two PCR assays had the same sensitivities for NTM detection, viz. 90.0%, and their specificities were 99.2% and 98.4%, respectively. The overall agreement rate between the three PCR assays was 96.5% for MTB and 97.9% for NTM. CONCLUSION: The sensitivities of PCR assays in our study might be overestimated, because this study enrolled relatively lower number of PCR-negative samples which potentially missed PCR-negative but culture-positive specimens. However, the two real-time PCR assays for detecting MTB and NTM perform equally well in relative performance evaluation and their Cq values can be considered suitable for predicting smear-positive specimens.

Soft-Templated Tellurium-Doped Mesoporous Carbon as a Pt-Free Electrocatalyst for High-Performance Dye-Sensitized Solar Cells.

Among various photovoltaic devices, dye-sensitized solar cells (DSSCs) are one of the most potentially clean and renewable energy conversion devices because of their low fabrication cost, environmentally friendly nature, and high power conversion efficiency. However, the use of rare metals such as Pt counter electrodes (CEs) is one of the major drawbacks of DSSC devices for broad real-life applications. In this regard, alternative materials to Pt CEs have been long sought for DSSCs employing both cobalt and iodine redox couples. Therefore, in this study, soft-templated tellurium-doped mesoporous carbons (Te-SMCs) were synthesized for the first time by the simple pyrolysis of PAN- b-PBA block copolymer in the presence of a tellurium precursor for replacing the Pt CE. To confirm the chemical composition and porosity, the as-prepared Te-SMC materials were evaluated by elemental analysis (XPS and EDS) and nitrogen sorption isotherms measurement. The as-prepared Te-SMC materials contained mainly mesopores and retained the three-dimensional hierarchical graphite-like structure with many defect sites. They displayed doping levels with nitrogen of 9.15 atom % and tellurium of 0.15 atom % and had a specific surface area of 540 m2 g-1. Therefore, these characteristics enabled the development of a high-performance CE in DSSCs with cobalt and iodine redox couples. As a result of its catalytic performance, Te-SMC exhibited outstanding electrocatalytic activity as well as a significantly improved electrochemical stability than those of Pt CE for both redox couples even after 1000 potential cycles. The results show that a maximum conversion efficiency of 11.64 and 9.67% could be achieved under one sun illumination (AM 1.5G) for SGT-021/Co(bpy)32+/3+- and N719/I-/I3--based devices with Te-SMC CEs, and their power conversion efficiency is superior to the corresponding device with Pt CEs.

A description of Mycobacterium chelonae subsp. gwanakae subsp. nov., a rapidly growing mycobacterium with a smooth colony phenotype due to glycopeptidolipids.

Three rapidly growing mycobacterial strains, MOTTH4W, MOTT36WT and MOTT68W, were isolated from the sputa of three independent Korean patients co-infected with Mycobacterium yongonense Type II strains. The 16S rRNA gene sequences of all three strains were unique, which were closest to that of Mycobacterium chelonae subsp. bovis KCTC 39630T (99.9 % similarity). Multilocus sequence typing analysis targeting 10 housekeeping genes including hsp65 and rpoB revealed the distinct phylogenetic location of these strains, which were clustered with M. chelonae subsp. chelonae ATCC 35752T and M. chelonae subsp. bovis KCTC 39630T. Phylogenetic analysis based on whole genome sequences revealed a 95.89 % average nucleotide identity (ANI) value with M. chelonae subsp. chelonae, slightly higher than the 95.0 % ANI criterion for determining a novel species. In addition, phenotypic characteristics such as a smooth colony morphology and growth inhibition at 37 °C, distinct MALDI-TOF MS profiles of extracted total lipids due to surface glycopeptidolipids, and distinct drug susceptibility profiles further supported the taxonomic characterization of these strains as representing a novel subspecies of Mycobacterium chelonae. Mycobacterium chelonae subsp. gwanakae subsp. nov. is proposed and the type strain is MOTT36WT (=KCTC 29127T=JCM 32454T).

A molecular epidemiological analysis of tuberculosis trends in South Korea.

Molecular epidemiological data are needed to assess tuberculosis (TB)-management policy outcomes in South Korea. IS6110 restriction fragment-length polymorphism (IS6110-RFLP) and mycobacterial interspersed repetitive unit-variable-number tandem repeat (MIRU-VNTR) analyses are major molecular epidemiological tools for investigating the transmission or reactivation of active TB. Here, we determined trends in the clustering rate (i.e., the prevalence of Mycobacterium tuberculosis isolates with identical genotype patterns) of active TB and related differences between the 1990s and 2000s in Korea. M. tuberculosis isolates (1,007) of nationwide origins were analyzed by IS6110-RFLP and 24-locus standardized MIRU-VNTR genotyping. The clustering rate was measured by IS6110-RFLP, 24-locus MIRU-VNTR, and both analytical methods in combination. IS6110-RFLP, 24-locus MIRU-VNTR typing, and the combined method revealed 882, 754, and 983 distinct profiles; 809, 651, and 961 unique isolates; and 198, 356, and 46 clustered isolates grouped into 73, 103, and 22 clusters, respectively. In addition, we confirmed that the clustering rates in the 2000s decreased by 11.2%, 2.1%, and 3.1% relative to that in the 1990s using the three methods, respectively. Furthermore, in multivariate analysis, the younger-age group (<30) clustered more frequently than the older-age group (>50), based on all the three methods. Our study is the first report to provide nationwide molecular epidemiological information on TB in Korea.